260 related articles for article (PubMed ID: 16133270)
1. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma.
Deb P; Sharma MC; Chander B; Mahapatra AK; Sarkar C
Childs Nerv Syst; 2006 Mar; 22(3):314-9. PubMed ID: 16133270
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
4. [Frontal giant cell glioblastoma: radio-induced tumor? Case report and literature review].
Lrhezzioui J; Emery E; Chapon F
Neurochirurgie; 2007 Dec; 53(6):486-90. PubMed ID: 18061629
[TBL] [Abstract][Full Text] [Related]
5. Gliosarcoma: a rare variant of glioblastoma multiforme.
Rizvi S; Asghar AH; Mehboob J
J Pak Med Assoc; 2010 Sep; 60(9):773-5. PubMed ID: 21381591
[TBL] [Abstract][Full Text] [Related]
6. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
[TBL] [Abstract][Full Text] [Related]
7. Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: case report.
Cheong JH; Kim CH; Kim JM; Oh YH
Clin Neurol Neurosurg; 2010 Oct; 112(8):701-6. PubMed ID: 20466481
[TBL] [Abstract][Full Text] [Related]
8. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
9. Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
Pierscianek D; Ahmadipour Y; Michel A; Rauschenbach L; Darkwah Oppong M; Deuschl C; Kebir S; Wrede KH; Glas M; Stuschke M; Sure U; Jabbarli R
Clin Neurol Neurosurg; 2021 Jan; 200():106348. PubMed ID: 33158630
[TBL] [Abstract][Full Text] [Related]
10. Pediatric giant cell glioblastoma: a case report and review of the literature.
De Prada I; Cordobés F; Azorín D; Contra T; Colmenero I; Glez-Mediero I
Childs Nerv Syst; 2006 Mar; 22(3):285-9. PubMed ID: 15999285
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
[TBL] [Abstract][Full Text] [Related]
12. Primary cerebral gliosarcoma: report of 17 cases.
Parekh HC; O'Donovan DG; Sharma RR; Keogh AJ
Br J Neurosurg; 1995 Apr; 9(2):171-8. PubMed ID: 7632363
[TBL] [Abstract][Full Text] [Related]
13. [Pediatric Gliosarcoma: Case Report and Literature Review].
Moscote-Salazara LR; Alcalá-Cerra G; Gutiérez-Paternina JJ; Penagos Gonzélezc PJ; Zubieta Vega C; Chater-Cure G; Alberto Meneses C; Saenz M
Bol Asoc Med P R; 2014; 106(3):43-7. PubMed ID: 25470910
[TBL] [Abstract][Full Text] [Related]
14. A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
Singh G; Mallick S; Sharma V; Joshi N; Purkait S; Jha P; Sharma MC; Suri V; Julka PK; Mahapatra AK; Singh M; Kale SS; Sarkar C
Neuropathology; 2012 Oct; 32(5):534-42. PubMed ID: 22380407
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
[TBL] [Abstract][Full Text] [Related]
16. Biological characteristics and outcomes of Gliosarcoma.
Hashmi FA; Salim A; Shamim MS; Bari ME
J Pak Med Assoc; 2018 Aug; 68(8):1273-1275. PubMed ID: 30108403
[TBL] [Abstract][Full Text] [Related]
17. An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.
Pietschmann S; von Bueren AO; Kerber MJ; Baumert BG; Kortmann RD; Müller K
PLoS One; 2015; 10(4):e0121592. PubMed ID: 25860797
[TBL] [Abstract][Full Text] [Related]
18. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
19. Giant infantile gliosarcoma: magnetic resonance imaging findings.
Sanal HT; Bulakbasi N; Kocaoglu M; Onguru O; Chen L
J Child Neurol; 2008 Aug; 23(8):926-9. PubMed ID: 18403585
[TBL] [Abstract][Full Text] [Related]
20. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
